Bing Center for Waldenstrom's Macroglobulinemia - Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia

You are here: Home

Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia